*Peptide data references* 
If you use the peptide data (shared via Example Data), please cite:

1) Jappe, E.C., Garde, C., Ramarathinam, S.H., Passantino, E., Illing, P.T., Mifsud, N.A., Trolle, T., Kringelum, J.V., Croft, N.P. and Purcell, A.W. (2020) Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design. Nature Communications, 11, 6305.
2) Shahbazy, M., Ramarathinam, S.H., Illing, P.T., Jappe, E.C., Faridi, P., Croft, N.P. and Purcell, A.W. (2023) Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics. Molecular & Cellular Proteomics, 22, 100515.
3) Schittenhelm, R.B., Dudek, N.L., Croft, N.P., Ramarathinam, S.H. and Purcell, A.W. (2014) A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4) – specific peptides. Tissue Antigens, 83, 174-179.
4) Illing, P.T., Vivian, J.P., Dudek, N.L., Kostenko, L., Chen, Z., Bharadwaj, M., Miles, J.J., Kjer-Nielsen, L., Gras, S., Williamson, N.A. et al. (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature, 486, 554-558.
5) Illing, P.T., Pymm, P., Croft, N.P., Hilton, H.G., Jojic, V., Han, A.S., Mendoza, J.L., Mifsud, N.A., Dudek, N.L., McCluskey, J. et al. (2018) HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nature Communications, 9, 4693.
6) Faridi, P., Woods, K., Ostrouska, S., Deceneux, C., Aranha, R., Duscharla, D., Wong, S.Q., Chen, W., Ramarathinam, S.H., Lim Kam Sian, T.C.C. et al. (2020) Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma. Cancer Immunology Research, 8, 1322-1334.
